A. Ernest Toth, Jr
2021
In 2021, A. Ernest Toth, Jr earned a total compensation of $1.1M as Chief Financial Officer at Aquestive Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $198,000 |
|---|---|
| Option Awards | $379,747 |
| Salary | $467,529 |
| Other | $14,367 |
| Total | $1,059,642 |
Toth received $467.5K in salary, accounting for 44% of the total pay in 2021.
Toth also received $198K in non-equity incentive plan, $379.7K in option awards and $14.4K in other compensation.
Rankings
In 2021, A. Ernest Toth, Jr's compensation ranked 8,597th out of 12,397 executives tracked by ExecPay. In other words, Toth earned more than 30.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,597 out of 12,397 | 31st |
Division Manufacturing | 3,806 out of 5,492 | 31st |
Major group Chemicals And Allied Products | 1,681 out of 2,367 | 29th |
Industry group Drugs | 1,497 out of 2,090 | 28th |
Industry Pharmaceutical Preparations | 1,115 out of 1,537 | 28th |
Source: SEC filing on April 29, 2022.
Toth's colleagues
We found two more compensation records of executives who worked with A. Ernest Toth, Jr at Aquestive Therapeutics in 2021.